BioNTech SE Free Cash Flow Generation Index
BioNTech SE free cash flow generation index. BioNTech SE (22UA) has a Free Cash Flow Generation Index of 0.80x as of December 2025. Free cash flow of €247.40 Million represents 1% of operating cash flow (€309.50 Million).
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of BioNTech SE (2021–2025)
Free cash flow generation index of BioNTech SE from 2021 to 2025. Historical FCF Generation Index trend for BioNTech SE across 5 annual periods. See BioNTech SE (22UA) flexibility index to measure the company's free cash flow as a share of total liabilities.
BioNTech SE Free Cash Flow Generation Index by Year (2021–2025)
BioNTech SE free cash flow generation index by year from 2021 to 2025. Year-by-year Free Cash Flow Generation Index for BioNTech SE. For the full cash flow conversion analysis, see how efficiently does BioNTech SE generate cash.
| Year | FCG Index | Free Cash Flow (EUR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.64x | €-293.00 Million | €456.00 Million | €749.00 Million | ▲ +45.4% |
| 2024 | -1.18x | €-244.60 Million | €207.70 Million | €452.30 Million | ▼ -235.6% |
| 2023 | 0.87x | €4.67 Billion | €5.37 Billion | €705.50 Million | ▼ -10.7% |
| 2022 | 0.97x | €13.21 Billion | €13.58 Billion | €363.30 Million | ▲ +17.7% |
| 2021 | 0.83x | €735.70 Million | €889.70 Million | €127.50 Million | — |